Skip to main content
Anuh Pharma Ltd. logo

Anuh Pharma Ltd. — Investor Relations & Filings

Ticker · ANUHPHR ISIN · INE489G01022 LEI · 335800IVKUOYQSJUVH89 BSE.NS Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS ANUHPHR

About Anuh Pharma Ltd.

https://www.anuhpharma.com

Anuh Pharma Ltd. is a manufacturer of Active Pharmaceutical Ingredients (APIs) and bulk drugs, specializing in the production of Macrolides, including Erythromycin salts, Azithromycin, and Clarithromycin. Its product portfolio also encompasses Anti-TB agents such as Pyrazinamide and Ethambutol, Anti-malarials like Chloroquine Phosphate, and a range of Corticosteroids including Dexamethasone and Betamethasone. Operating with global quality standards, the company maintains certifications such as WHO-GMP, EU-GMP, and CEP. Anuh Pharma focuses on large-scale manufacturing and the supply of high-quality intermediates to pharmaceutical formulators worldwide. The organization leverages advanced chemical synthesis capabilities to serve diverse therapeutic segments, ensuring consistent supply chain reliability and regulatory compliance across international markets.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 85% confidence The document is an official intimation sent to the stock exchanges under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying the re-classification of certain shareholders from the “Promoter Group” to “Public” category. It is a compliance announcement rather than a full financial report, earnings release, management change notice, or share issuance. It does not contain substantive financial statements or qualify as an annual/interim report, and it is not a director dealing or dividend notice. Therefore, it best fits the fallback category for general regulatory announcements under “Regulatory Filings” (RNS).
2026-05-22 English
Intimation for the Resolution for reclassification of shareholders from Promoter group to Public category
Regulatory Filings Classification · 90% confidence The document is an intimation under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations providing a certified true copy of a Board resolution approving the re-classification of certain shareholders from the promoter group to public category. It is a regulatory compliance announcement to stock exchanges rather than a financial report or capital raising document. It does not involve share issuance, dividend notice, management change, or earnings data. It falls under general regulatory filings.
2026-05-22 English
Newspaper Publication of the Audited financial results for the Quarter and Year ended 31st March, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi ....
Regulatory Filings
2026-05-22 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 89% confidence The document is a formal letter to stock exchanges (BSE & NSE) under SEBI LODR Reg. 47 informing them that the company’s audited quarterly and annual financial results were published in newspapers (copies enclosed). Although extracts of the figures appear, this is not the full interim/annual report itself but a notice/advertisement of its publication. Under our “menu vs meal” rule such notices are classified as Report Publication Announcements (RPA).
2026-05-22 English
Updates
Earnings Release Classification · 80% confidence The document is an official stock exchange announcement titled “Outcome of Board Meeting dated 20th May, 2026” under SEBI LODR Regulations. It contains the audited financial results for the quarter and financial year ended 31 March 2026, statutory auditor’s report, dividend recommendation and other board decisions. It is not a full Annual Report (10-K), but is the company’s first public release of its periodical financial results (including key line‐items and detailed tables). Therefore, this is best classified as an Earnings Release. FY 2026
2026-05-20 English
Updates
Interim / Quarterly Report Classification · 85% confidence The document is a board meeting outcome notice under SEBI LODR, attaching the audited financial results for the quarter and year ended March 31, 2026, including full P&L and balance sheet statements. It is more than just a high‐level earnings release, containing comprehensive interim financial statements, so it qualifies as an Interim/Quarterly Report rather than a simple earnings release or annual report announcement. FY 2026
2026-05-20 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.